NNG.WA

Compare

No price history available for this symbol yet.

Fair-value model

Consensus-seeded revenue, margins, and exit multiples. This is a scenario tool, not investment advice.

Years of analysisAssumption entries

Analyst estimates unavailable for this ticker.

Held by

portfolios on TandT

Bookmarked by

users

Avg position size

—

of holders' portfolios

13F filers

institutions

Sector

Biotechnology

DCF fair valuemodel estimate

Intrinsic value

$0.47

Price

$2.46

Implied downside

-81%

Peer comparison

Symbol	Price	Today	Mkt cap	P/E
NNG.WANanoGroup S.A.	$2.42	-1.83%	$103M	—
AWM.WAAirway Medix S.A.	$0.28	-0.36%	$32M	—
BMX.WABioMaxima S.A.	$10.14	-0.39%	$43M	—
GMT.WAGenomtec S.A.	$3.61	+0.00%	$62M	—
ICE.WAMedinice S.A.	$57.40	-4.17%	$533M	—
MAB.WAMabion S.A.	$7.91	-1.13%	$128M	—
MOC.WAMolecure S.A.	$7.63	+3.39%	$189M	—

Source: Financial Modeling Prep · peers by sector/industry

NanoGroup S.A.

NanoGroup S.A. operates as a biotechnology company in Poland. It engages in the production of medicines and other pharmaceutical products, and research and development work in the field of biotechnology and other natural and technical sciences. The company is also involved in technical research and analysis. In addition, it manages a portfolio of companies that manage projects to meet the needs of modern medicine in the field of oncology and transplantology. The company was founded in 2016 and is based in Warsaw, Poland.

nanogroup.eu

Employees: 46
IPO / List date: Mar 14, 2018
HQ: PL

Held by traders on TradeandTell

No one on the platform currently holds NNG.WA.

Super investors & insiders

Institutions holding (13F)

No tracked institution reports a position in NNG.WA as of their last filing.

Insider activity (SEC Form 4)

No recent Form 4 filings on EDGAR — either no insider transactions reported recently or this isn't a SEC-registered issuer.

Insider activity (SEC Form 4)

Recent trades on TradeandTell

No one on the platform has traded NNG.WA yet.